ADIM
BALY icon

Alpha DNA Investment Management’s Bally's BALY Stock Holding History

Alpha DNA Investment Management’s Portfolio BALY Stock Details BALY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23
Closed -$1K – 151
2021
Q1 		$1K Sell
23
-8
-26% -$474 ﹤0.01% 608
2020
Q4 		$1K Buy
+31
New +$1.09K ﹤0.01% 509

Other funds holding BALY

SG
Standard General New York $336M AUM 16.52% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Alpha DNA Investment Management's BALY Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Bally's (BALY) in Q2 2021, closing a stake of 23 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in BALY in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 160 funds tracked by Wall St. Rank hold BALY as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Bally's position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 23 Bally's shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Bally's in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Bally's position peaked at $1K in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Bally's as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.